Fact-checked by Grok 2 weeks ago

Basic metabolic panel

The basic metabolic panel (BMP), also known as a chem 7 or metabolic 7, is a routine that measures eight essential substances in the blood to provide a snapshot of a person's metabolic , including function, balance, acid-base status, and blood glucose levels. This panel is typically ordered as part of preventive screenings, diagnostic evaluations for symptoms like or , or monitoring during hospitalization and treatment for conditions such as or . The BMP assesses critical aspects of bodily function by analyzing levels of electrolytes (sodium, potassium, chloride, and bicarbonate), which help regulate , signals, and muscle contractions; kidney markers ( and ), which indicate how well the s are filtering waste; calcium, vital for and cellular signaling; and glucose, a primary energy source that reflects blood sugar control. It also calculates the from these values to evaluate acid-base balance, aiding in the detection of imbalances like . Abnormal results can signal issues such as , kidney impairment, complications, or disturbances, prompting further investigation. The test is performed by drawing a small blood sample from a in the , usually requiring no special beyond possible for 8-12 hours to ensure accurate glucose measurement, and results are typically available within hours to a day. Normal reference ranges vary slightly by laboratory but generally include: glucose (70-99 mg/dL), calcium (8.5-10.2 mg/dL), sodium (135-145 mEq/L), (3.5-5.0 mEq/L), (98-106 mEq/L), (22-29 mEq/L), BUN (6-20 mg/dL), and (0.6-1.2 mg/dL for adults). The BMP is distinct from the more extensive (CMP), which adds .

Overview

Definition

The basic metabolic panel (BMP), also known as the basic metabolic profile, is a common group of eight tests that measures key substances to assess essential metabolic functions in the body. These tests evaluate levels of glucose, which indicates sugar status; electrolytes including sodium, potassium, chloride, and (reported as total carbon dioxide); minerals such as calcium; and markers of kidney function like () and . The panel is typically ordered as a single draw to provide a snapshot of , equilibrium, glucose regulation, and renal health. Introduced in clinical laboratories during the late , the BMP emerged as part of the evolution of automated analyzers that streamlined routine biochemical testing. Building on earlier innovations like the Sequential Multiple Analyzer with Computer (SMAC) developed by Technicon Corporation in the 1970s, which enabled high-throughput analysis of multiple analytes from one sample, the BMP standardized a core set of eight tests to improve efficiency in patient screening and monitoring. This automation reduced manual labor and turnaround times, making such panels a cornerstone of modern laboratory medicine by the 1980s and 1990s. Unlike imaging techniques or other diagnostic modalities, the BMP is exclusively a biochemical performed on or from a sample, focusing solely on , glucose, calcium, and renal parameters without incorporating hematological elements like a or hormonal assays.

Purpose and Indications

The basic metabolic panel () is primarily ordered to evaluate key aspects of metabolic health, including balance, function, blood levels, and acid-base status. This test provides essential information on how the body maintains fluid and equilibrium, processes nutrients, and regulates , which are critical for overall physiological stability. By assessing these parameters, healthcare providers can identify potential disruptions in metabolic processes that may signal underlying health issues. Indications for ordering a BMP include routine screenings during physical examinations to establish a baseline for metabolic function. It is also commonly used to monitor chronic conditions such as , , or , where regular assessment helps track disease progression or efficacy. Preoperative screening often incorporates the BMP to ensure patients are metabolically stable before surgery, while symptoms suggestive of , persistent , or unexplained may prompt its use to investigate or glucose imbalances. In emergency settings, the test is frequently performed to evaluate acute conditions like kidney injury, where rapid assessment of renal markers and s is vital. The benefits of the BMP lie in its ability to deliver a rapid, comprehensive snapshot of fluid and status, often with results available within hours in urgent situations or 1-2 days otherwise. This facilitates early detection of metabolic imbalances that, if untreated, could progress to serious complications such as cardiac arrhythmias from disturbances or from glucose dysregulation. By enabling timely interventions, the test supports preventive care and reduces the risk of acute health deteriorations across diverse clinical scenarios.

Components

Electrolytes and Acid-Base Balance

The electrolytes measured in the basic metabolic panel ()—sodium, , , and —play essential roles in maintaining , and muscle function, and acid-base throughout the body. These ions are primarily extracellular, with sodium and chloride dominating the compartment, while is predominantly intracellular. Imbalances in these electrolytes can arise from various physiological disruptions, such as , medication effects, or underlying diseases, and the BMP provides a snapshot to evaluate these critical parameters. Sodium (Na+) is the primary cation in , essential for regulating fluid volume and , as well as facilitating nerve impulse transmission and through its role in the sodium-potassium pump (Na+/K+-ATPase). It is actively reabsorbed in the kidneys, influenced by s like aldosterone, to preserve extracellular volume. , a low sodium level, often results from overhydration or conditions like syndrome of inappropriate antidiuretic hormone secretion (SIADH), leading to cellular swelling and neurological symptoms such as confusion or seizures. Potassium (K+), the major intracellular cation, is vital for maintaining resting , enabling proper heart rhythm, contraction, and nerve signaling. Its levels are tightly regulated by renal , particularly in the distal tubules under aldosterone control, and by the Na+/K+-ATPase pump that shifts it into cells. , an elevated potassium level, is frequently associated with renal failure, where impaired allows accumulation, potentially causing life-threatening cardiac arrhythmias. Chloride (Cl-) serves as the principal extracellular anion, closely paralleling sodium movement to maintain electroneutrality and across compartments. It contributes to production as (HCl) for and supports in body fluids. Chloride imbalances often accompany sodium disturbances; for instance, can occur with prolonged vomiting due to loss of HCl, while may result from loss in . Bicarbonate (HCO3-), reported in the BMP as total (CO2) content, is the key for maintaining acid-base , neutralizing excess acids to stabilize pH. It is generated and reabsorbed by the kidneys and lungs, with serum levels reflecting the body's compensatory mechanisms against respiratory or metabolic disturbances. Low levels indicate , often from conditions like or , while elevated levels suggest , as seen in or use. These electrolytes interrelate to ensure overall ; for example, sodium, chloride, and bicarbonate form the basis for calculating the , a derived value that helps differentiate causes of . The is computed as: \text{Anion gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) This simple formula identifies unmeasured anions (e.g., or ketones) when elevated, guiding in acidotic states, while a normal gap points to hyperchloremic causes like . Such interrelations underscore the BMP's utility in assessing integrated and acid-base function.

Glucose and Calcium

The basic metabolic panel (BMP) measures blood glucose levels, which provide a snapshot of and serve as the body's source derived from dietary intake. Glucose is typically quantified in milligrams per deciliter (mg/dL) through either plasma glucose, following an 8- to 12-hour from food and drink, or random plasma glucose, to assess overall glycemic control. This measurement reflects insulin function, as the secreted by pancreatic cells promotes glucose uptake into cells via transporters like , facilitating energy production through and subsequent pathways. Elevations in glucose levels within the BMP can indicate , often signaling or diabetes mellitus, while low levels may point to , aiding in early screening for metabolic disorders. Calcium measurement in the BMP evaluates total serum calcium, a vital of which approximately 99% of the total body content is stored in the as for structural integrity, with the remaining approximately 1% distributed in blood and soft tissues. calcium, reported in mg/dL (normal range approximately 8.8–10.4), encompasses three forms: ionized (free and biologically active, ~50%), protein-bound (primarily to , ~40%), and complexed with anions like (~10%), with the ionized fraction directly influencing cellular processes. This component is essential for bone health through mineralization, via regulation of actin-myosin cross-bridging, and nerve signaling by maintaining and excitability. Imbalances in calcium levels detected via the may suggest disorders, such as causing excessive secretion, or impairing intestinal absorption and leading to reduced serum levels. Calcium regulation also involves interactions with electrolytes like and magnesium for .

Renal Function Markers

The Basic Metabolic Panel (BMP) includes two key markers for assessing renal function: Blood Urea Nitrogen (BUN) and creatinine, which provide insights into the kidneys' ability to filter waste products from the blood. Blood Urea Nitrogen (BUN) measures the amount of urea nitrogen, a waste product formed when the body breaks down proteins, which the kidneys normally filter and excrete in urine. Elevated BUN levels can indicate dehydration, which reduces blood flow to the kidneys and impairs filtration, or reduced kidney function due to intrinsic renal issues. Creatinine, in contrast, is a waste product generated from the normal of in muscle and is filtered by the glomeruli in the . Unlike , is more specific for evaluating (GFR), the rate at which the clear waste from the blood, and it serves as a basis for estimating overall kidney clearance through formulas like the estimated GFR (). The BUN-to-creatinine ratio is calculated as Ratio = BUN (mg/dL) / Creatinine (mg/dL) and typically ranges from 10:1 to 20:1 in healthy individuals; this ratio helps differentiate prerenal causes of kidney dysfunction, such as dehydration, from intrinsic renal causes like acute tubular necrosis, where the ratio may fall below 10:1 or exceed 20:1 depending on the underlying pathology. These markers have limitations influenced by non-renal factors: BUN can be elevated by a high-protein diet, while creatinine levels vary with muscle mass (higher in individuals with greater muscle bulk and lower in those with reduced mass, such as the elderly or malnourished), and medications like angiotensin-converting enzyme (ACE) inhibitors can increase creatinine by altering renal hemodynamics without necessarily indicating true kidney damage. Kidney dysfunction reflected by abnormal BUN or creatinine may also contribute to electrolyte imbalances, such as hyperkalemia.

Procedure

Patient Preparation

Patients undergoing a basic metabolic panel () test are often advised to fast for 8 to 12 hours prior to the blood draw to ensure accurate measurement of glucose levels, as food intake can elevate blood sugar and skew results. During this period, only is permitted, and is encouraged to facilitate sample collection and maintain balance. However, is not always mandatory for all BMP components, such as electrolytes or renal markers, and healthcare providers may waive it based on clinical context to avoid unnecessary discomfort. Individuals should inform their healthcare provider about all medications, supplements, and over-the-counter drugs they are taking, as certain ones can interfere with results. For instance, diuretics may alter sodium, , and levels; insulin or oral hypoglycemics can affect glucose; and corticosteroids might influence glucose, calcium, or electrolytes. Providers may recommend temporarily adjusting or withholding such medications if safe, but this decision depends on the patient's overall health and treatment needs. To minimize potential impacts on renal function markers, patients are generally instructed to avoid strenuous exercise for 24 hours before the test, as intense physical activity can cause temporary elevations in and () due to muscle breakdown and . Similarly, abstaining from for at least 24 hours is recommended, as consumption can lead to , imbalances, and fluctuations in glucose. These precautions help ensure the test reflects metabolic status rather than transient effects. For special populations, preparation guidelines may be tailored to reduce risks or accommodate needs. In pregnant individuals, non-fasting options might be preferred to avoid , with adjustments based on screening protocols. Children and elderly patients often follow similar fasting rules but with closer monitoring for or compliance issues; pediatric doses of medications and activity restrictions are also considered to prevent undue stress. Always consult the ordering provider for personalized instructions.

Sample Collection and Laboratory Processing

The basic metabolic panel (BMP) requires a blood sample obtained through , typically from a in the antecubital fossa of the arm. A healthcare professional uses a sterile needle to draw approximately 5 of blood into a serum separator tube (SST), which contains a barrier and clot activator to facilitate separation. This minimal volume is sufficient for the analysis of all eight BMP components, minimizing patient discomfort while ensuring adequate sample yield. Following collection, the sample undergoes laboratory processing to isolate for analysis. If using a plain red-top tube, the blood is allowed to clot for 30 minutes at before ; SST tubes accelerate this process. occurs within 2 hours of collection at a speed greater than 2500 × g for 10 minutes at to separate from cellular components, with the forming a barrier to prevent remixing. The resulting is aliquoted into a secondary and stored at 2–8°C if not analyzed immediately, maintaining stability for up to 7 days. Analysis of the employs automated analyzers, which process multiple samples efficiently. Electrolytes (sodium, potassium, chloride, and ) are measured using -selective electrodes (ISEs), where the potential difference across a selective generates a voltage proportional to activity, calibrated against standards for accuracy. Glucose is quantified via enzymatic methods, such as or , which produce a chromogenic or fluorometric signal proportional to concentration. (BUN) utilizes to hydrolyze into , detected enzymatically or colorimetrically, while employs enzymatic (e.g., by creatininase) followed by coupled reactions for precise measurement, avoiding interferences common in older Jaffé methods. These automated systems handle high throughput, with pipetting, mixing, and detection integrated into a single platform. Results from BMP processing are typically available within 1 day, often in a few hours for routine inpatient or outpatient testing, due to the speed of automated analyzers. In settings, point-of-care devices like portable analyzers can deliver results in under 15 minutes using or minimal , enabling rapid clinical decision-making. Laboratory quality control adheres to Clinical Laboratory Improvement Amendments (CLIA) guidelines, ensuring analytical reliability. Analyzers are calibrated daily with multi-level standards traceable to NIST reference materials, and internal quality control samples—low, normal, and high concentrations—are run with each batch to verify precision and accuracy, with applied to detect systematic errors. Proficiency testing through external programs, such as those from CMS-approved providers, occurs at least semiannually to confirm inter-laboratory comparability.

Interpretation

Reference Ranges

The basic metabolic panel (BMP) includes measurements of glucose, calcium, sodium, potassium, chloride, bicarbonate (CO2), , and , with reference ranges established by clinical laboratories based on population studies. These ranges represent typical values for healthy adults and may vary slightly between laboratories due to differences in analytical methods and equipment. Standard reference ranges for BMP components in adults are as follows:
ComponentReference Range (Adults)UnitsNotes
70–99 mg/dLmg/dLEquivalent to 3.9–5.5 mmol/L; non-fasting values may be higher.
Calcium8.5–10.2 mg/dLmg/dLEquivalent to 2.1–2.5 mmol/L.
Sodium135–145 mEq/LmEq/L or mmol/LmEq/L and mmol/L are equivalent for monovalent ions like sodium.
3.5–5.0 mEq/LmEq/L or mmol/LmEq/L and mmol/L are equivalent.
98–106 mEq/LmEq/L or mmol/LmEq/L and mmol/L are equivalent.
23–29 mEq/LmEq/L or mmol/LmEq/L and mmol/L are equivalent; reflects total CO2 content.
6–20 mg/dLmg/dLEquivalent to 2.1–7.1 mmol/L; lower in children.
Males: 0.74–1.35 mg/dL; Females: 0.59–1.04 mg/dLmg/dLEquivalent to 65–119 µmol/L (males) and 52–92 µmol/L (females); varies by muscle mass.
These values are derived from enzymatic or colorimetric assays standardized to international references, such as those from the International Federation of . Reference ranges can be influenced by demographic factors, including age, sex, and status. For instance, levels are higher in males due to greater muscle mass and decline with age in both sexes; in , sodium may decrease by 2–5 mEq/L due to expanded volume, while remains relatively stable. Additionally, methods affect results; the enzymatic for is preferred over the older Jaffe method, which can overestimate values by up to 0.2 mg/dL at low concentrations due to interference from non- chromogens, potentially altering reference ranges by 10–20%. Laboratories often adjust ranges accordingly and report method-specific values to ensure clinical accuracy.

Abnormal Results and Diagnostic Implications

Abnormal results in a basic metabolic panel () provide initial clues to disruptions in electrolyte balance, glucose metabolism, or renal function, but must be interpreted in the context of clinical history, symptoms, and additional testing, as isolated values rarely confirm a . For instance, elevated fasting glucose levels exceeding 126 mg/dL suggest diabetes mellitus, prompting further evaluation such as hemoglobin A1c testing to confirm chronic . Similarly, low sodium concentrations below 135 mEq/L () may indicate syndrome of inappropriate antidiuretic hormone secretion (SIADH) or , where fluid overload dilutes serum sodium. Integrated analysis of BMP components reveals patterns with specific diagnostic implications; for example, concurrent elevations in () and often signal potential renal impairment, with (AKI) characterized by a rapid rise in by at least 0.3 mg/dL within 48 hours or to 1.5 times baseline. In such cases, the BUN-to- ratio can help differentiate prerenal causes like (ratio >20:1) from intrinsic renal damage. An elevated , calculated as sodium minus ( + ) and typically >12 mEq/L, points to from conditions like or , guiding targeted interventions such as arterial blood gas analysis. Diagnostic steps following abnormal BMP results involve confirmatory tests tailored to the suspected issue; for persistent , glycosylated hemoglobin (HbA1c) assessment establishes long-term control, while renal abnormalities may warrant or to identify obstruction or . Hyponatremia evaluation often includes serum osmolality measurement to distinguish true hypotonic states from pseudohyponatremia, where high lipids or proteins artifactually lower sodium readings via indirect methods. In AKI patterns, helps classify etiology, potentially leading to renal ultrasound if structural issues are suspected. Common pitfalls in BMP interpretation include pseudohyponatremia due to (>1500 mg/dL) or paraproteinemia, which can be resolved by direct ion-specific electrode assays or lipid correction formulas. Other factors, such as recent meals affecting glucose or medications influencing , underscore the need for repeat testing and correlation with reference ranges to avoid misdiagnosis.

Clinical Applications

Routine Screening and Monitoring

The basic metabolic panel (BMP) is commonly incorporated into routine health screenings for adults, especially those aged 40 and older or at elevated risk for metabolic syndrome, to identify early signs of diabetes through glucose measurement and hypertension through electrolyte evaluation. This proactive approach helps detect subclinical imbalances before they manifest as overt disease, supporting preventive care in primary settings. For instance, the U.S. Preventive Services Task Force (USPSTF) recommends screening for prediabetes and type 2 diabetes with blood glucose testing in asymptomatic adults aged 35 to 70 years who are overweight or obese, with BMP often fulfilling this role as part of broader metabolic assessment. Screening frequency is typically annual for high-risk groups, such as individuals with obesity or family history of metabolic disorders, aligning with guidelines from organizations like the American Academy of Family Physicians (AAFP) for periodic laboratory evaluation during well-visits. Beyond initial screening, the BMP is essential for ongoing monitoring of therapeutic efficacy in chronic conditions. In heart failure management, for example, patients on diuretic therapy undergo regular BMP testing to track levels and renal markers like and (BUN), ensuring adjustments to prevent or worsening kidney function. Similarly, during regimens, BMP monitoring assesses kidney stress from nephrotoxic agents by evaluating balance and glomerular filtration indicators, allowing timely dose modifications to maintain safety. The (ADA) recommends annual assessment of renal function using serum to calculate estimated (eGFR) and monitoring of glycemic control for adults with , with BMP commonly used for these purposes and more frequent testing based on individual risk factors like medication use or comorbidities. Early intervention facilitated by routine BMP screening and monitoring significantly improves health outcomes by reducing morbidity from metabolic disorders. For identified via elevated glucose, lifestyle modifications such as and exercise can prevent progression to in up to 58% of cases, as evidenced by the Diabetes Prevention Program study.

Acute Care and Diagnosis

In settings, such as the , the basic metabolic panel (BMP) serves as a rapid diagnostic tool for assessing critical imbalances that require immediate intervention. It enables quick evaluation of disturbances, glucose levels, and renal function markers like (BUN), which can signal life-threatening conditions. For instance, elevated BUN levels often indicate due to reduced renal , prompting urgent fluid to prevent complications like . The is particularly valuable in managing emergencies, such as , which may arise in patients from damage and leading to release. A confirms elevated (>5.5 mEq/L), guiding treatments like for cardiac stabilization or insulin with glucose to shift intracellularly. In , low (CO2) levels on the suggest , often from accumulation, helping clinicians prioritize antibiotics and supportive care to address the underlying infection and acid-base derangement. As a diagnostic , the helps differentiate causes of nonspecific symptoms like or . For , low sodium ( <135 mEq/L) versus low glucose (hypoglycemia <70 mg/dL) can be distinguished through BMP results, allowing targeted correction—such as hypertonic saline for severe or dextrose for hypoglycemia—to avert neurological deterioration. Similarly, in patients with , the panel identifies hypocalcemia (<8.5 mg/dL), which may cause neuromuscular irritability, versus hyperkalemia, which leads to flaccid paralysis, informing decisions on calcium supplementation or potassium-lowering therapies. The BMP integrates directly into acute care protocols by guiding immediate interventions and facilitating serial monitoring. For example, intravenous fluids are administered for detected imbalances like dehydration or hyponatremia, with repeat BMPs every 4-6 hours to track resolution and adjust therapy. In diabetic ketoacidosis (DKA), a classic acute scenario, the BMP reveals hyperglycemia (>250 mg/dL), low bicarbonate (<18 mEq/L), and an elevated anion gap (calculated as sodium minus [chloride + bicarbonate] >12 mEq/L), prompting insulin infusion and fluid replacement to reverse ketosis and acidosis.

Limitations and Considerations

Factors Affecting Results

Several factors can influence the accuracy of basic metabolic panel (BMP) results, categorized into pre-analytical, physiological, analytical, and post-analytical phases. These variables may lead to spurious alterations in measured analytes such as , electrolytes, (), and , potentially complicating clinical assessment. In the pre-analytical phase, sample collection and handling errors are primary contributors to inaccurate results. , the rupture of red blood cells during collection or transport, releases intracellular , causing falsely elevated serum levels that can mimic . Improper storage or delayed separation of serum from cells allows continued , resulting in artifactual decreases in glucose concentrations by approximately 5-7% per hour at . Such delays can also affect stability, with studies showing significant variation in levels, up to approximately 24% increase in kinetic Jaffe methods after 24 hours without . Proper patient preparation, as outlined in procedural guidelines, helps mitigate these issues by standardizing collection techniques. Physiological factors introduce biological variability unrelated to disease. A increases levels by enhancing urea production from . Strenuous exercise transiently raises through muscle and reduced renal perfusion, potentially increasing serum levels by 20-50% immediately post-activity, though values normalize within hours. Circadian rhythms affect glucose, with peaks occurring in the early morning due to the , where hepatic glucose output rises by up to 30 mg/dL before breakfast, independent of insulin dynamics. Analytical phase errors arise from processes and . Reagent contamination or drift can distort measurements across analytes; for instance, contaminated ion-selective electrodes may yield erroneous sodium or readings by 5-10 mEq/L. Inter-laboratory variability is notable in assays, where the traditional Jaffe kinetic method overestimates values by 10-20% due to interferences from , acetoacetate, and cephalosporins, compared to more specific enzymatic methods. Standardization efforts, such as those recommended by the Clinical and Laboratory Standards Institute, aim to minimize these discrepancies through uniform assay protocols. Post-analytical factors involve result reporting and interpretation. Differences in reporting units—such as mg/dL versus mmol/L for or —can lead to misinterpretation if not clearly indicated, potentially causing errors in dose calculations or threshold assessments.

Comparison to

The () and () are both common tests that evaluate key aspects of metabolic , but they differ in scope and components. The consists of eight tests focusing on , electrolyte balance, sugar, and calcium levels, including , calcium, sodium, , , , (), and . In contrast, the expands on this by incorporating all eight tests plus six additional measurements related to liver and protein status: , total protein, (), (), (), and total . This makes the a more extensive panel with 14 tests total, providing insights into hepatic health that the lacks. Clinically, the choice between BMP and CMP depends on the patient's presentation and the need for targeted versus holistic assessment. The BMP is often preferred in urgent settings, such as emergency rooms, for rapid evaluation of kidney function and electrolyte imbalances in conditions like or , allowing for quicker turnaround times. The CMP, however, is typically ordered for routine health screenings or when symptoms suggest broader metabolic or liver involvement, such as , , or , enabling detection of issues like or nutritional deficiencies. For instance, in patients with suspected , the CMP's inclusion of and total protein offers a fuller picture of protein status that the BMP cannot provide. In terms of efficiency and cost, the BMP is generally less expensive and faster to process due to its limited number of analytes, with out-of-pocket costs ranging from $10 to $80 without , compared to $20 to $100 for the CMP. This in the CMP justifies its use when liver evaluation is warranted, as the extra tests can prevent the need for separate liver function panels, though it increases both processing time and expense. Both panels share the core eight tests, ensuring overlap in basic metabolic screening, but the CMP's broader profile makes it indispensable for comprehensive diagnostic workups.

References

  1. [1]
    Basic Metabolic Panel (BMP): What It Is, Procedure & Results
    A basic metabolic panel (BMP) is a common blood test that measures eight different substances in your blood, including electrolytes and glucose.
  2. [2]
    Basic Metabolic Panel (BMP): MedlinePlus Medical Test
    Sep 10, 2024 · A basic metabolic panel (BMP) measures eight different substances in your blood. It provides important information about your body's fluid balance, your ...Understand Medical Research · Chloride Blood Test · Calcium
  3. [3]
    Basic Metabolic Panel, Serum - BMAMA - Mayo Clinic Laboratories
    It is used to assess kidney status, electrolyte, and acid/base balance, and blood glucose.
  4. [4]
    Basic Metabolic Panel (8) | Labcorp Test 322758, CPT 80048
    Sep 30, 2025 · Metabolic Panel (8), Basic ; CPT. 80048 ; Synonyms. Basic Metabolic Panel ; Specimen. Serum (preferred) or plasma ; Volume. 1 mL ; Minimum Volume.
  5. [5]
    Blood Tests - NHLBI - NIH
    Mar 24, 2022 · The basic metabolic panel (BMP) is a group of tests that measures different naturally occurring chemicals in the blood. These tests usually are ...
  6. [6]
    Clinical Chemistry Laboratory Automation in the 21st Century
    The autoanalyser reached its highwater mark with the SMAC (Sequential Multiple Analyzer with Computer) in 1974, which had a built-in computer. The AutoAnalyzer ...
  7. [7]
    1-3.Standardization of laboratory automation systems:transportation ...
    In 1972, Technicon developed SMAC-1 AutoAnalyzer and then began shipping the unit in 1974. The SMAC-1 was first installed at Kanazawa Medical University.
  8. [8]
    Electrolytes - StatPearls - NCBI Bookshelf - NIH
    Jul 24, 2023 · This article reviews the basic physiology of electrolytes and their abnormalities, and the consequences of electrolyte imbalance. Sodium. Sodium ...
  9. [9]
    Hyponatremia - Symptoms and causes - Mayo Clinic
    Jul 18, 2025 · Sodium is an electrolyte, and it helps regulate the amount of water that's in and around your cells. In hyponatremia, one or more factors cause ...
  10. [10]
    Hyperkalemia in chronic kidney disease - PubMed
    Jan 13, 2020 · Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ...
  11. [11]
    Biochemistry, Anion Gap - StatPearls - NCBI Bookshelf
    For reference, a normal anion gap depends on the concentration of phosphate and albumin in the serum and ranges from 4 to 12 mmol/L. An increased or normal ...Introduction · Fundamentals · Pathophysiology
  12. [12]
    Physiology, Glucose - StatPearls - NCBI Bookshelf - NIH
    Apr 30, 2024 · Normal oral glucose tolerance test results indicate efficient glucose uptake and insulin secretion, indicative of intact glucose metabolism.Physiology, Glucose · Organ Systems Involved · Clinical SignificanceMissing: panel | Show results with:panel
  13. [13]
    Calcium - StatPearls - NCBI Bookshelf - NIH
    Fasting is not a requirement to evaluate serum calcium levels. Calcium is included in the comprehensive metabolic panel (CMP), facilitating routine evaluation.
  14. [14]
    Physiology, Calcium - StatPearls - NCBI Bookshelf - NIH
    Calcium is an essential element that serves an important role in skeletal mineralization ... Clinical Significance. It is important for the clinician to be ...Missing: panel | Show results with:panel
  15. [15]
    Renal Function Tests - StatPearls - NCBI Bookshelf - NIH
    When BUN levels are increased, the BUN-to-creatinine ratio can be useful to differentiate pre-renal from renal causes. In pre-renal disease, the ratio is close ...
  16. [16]
    Blood urea nitrogen (BUN) test - Mayo Clinic
    Aug 5, 2023 · A common blood test, the blood urea nitrogen (BUN) test reveals important information about how well your kidneys are working.
  17. [17]
    BUN and Creatinine - Clinical Methods - NCBI Bookshelf - NIH
    The BUN and creatinine, taken together, are valuable screening tests in evaluating renal disease. Though they may fall short as absolute indicators of renal ...
  18. [18]
    The long-term effects of blood urea nitrogen levels on ...
    May 16, 2024 · BUN levels are affected by several factors, including dehydration, protein intake, gastrointestinal bleeding, and liver disease; previous ...
  19. [19]
    Serum creatinine elevation after renin-angiotensin system blockade ...
    Mar 9, 2017 · Most importantly, patients with substantial increases in creatinine after starting ACEI/ARB treatment should be recognised as a very high risk ...Missing: muscle | Show results with:muscle
  20. [20]
    Basic Metabolic Panel (Blood)
    This blood test gives information about your body's metabolism, or how your body uses food for energy. It gives a snapshot of the health of your kidneys.
  21. [21]
    Comprehensive Metabolic Panel
    This test is a screening panel of 14 tests that look at your metabolism. Your body gets energy from food through a process called metabolism.
  22. [22]
    [PDF] Understanding Your Lab Values - Williams County
    High values may mean that the kidneys are not working as well as they should. BUN is also affected by high protein diets, steroids, and/or strenuous exercise ...
  23. [23]
    How to Prepare for a Lab Test: MedlinePlus Medical Test
    Aug 20, 2024 · One of the most common lab test preparations is fasting. Fasting means you should not eat or drink anything except water for up to several hours or overnight ...Missing: metabolic populations
  24. [24]
    Blood Glucose Test: MedlinePlus Medical Test
    Dec 30, 2024 · If your glucose test is part of a BMP or CMP test, you may need to fast. Other blood glucose tests don't require any special preparations.Missing: populations elderly
  25. [25]
    Test Code KPNL Basic Metabolic Panel (BMP)
    May 21, 2025 · Samples should be centrifuged within 2 hours of collection. · Centrifuge specimens at >2500 x g for 10 minutes at room temperature. · Aliquot ...Missing: venipuncture | Show results with:venipuncture
  26. [26]
    Basic Metabolic Panel - Cleveland HeartLab, Inc.
    Aug 13, 2013 · DO NOT SHAKE. Allow blood to clot 30 minutes. Centrifuge for 10 minutes. Transport: Store serum at 2°C to 8°C after collection ...Missing: processing analyzers
  27. [27]
    Use of ion-selective electrodes for blood-electrolyte analysis ...
    This paper will familiarize the reader with the terms used to describe the behavior of ion-selective electrodes, particularly in relation to their use in ...
  28. [28]
    Glucose Assay - an overview | ScienceDirect Topics
    Most glucose assays use enzymatic methods, based on either glucose dehydrogenase, glucose oxidase (coupled to ferricyanide) or glucose hexokinase.
  29. [29]
    How Long Does It Take to Get Blood Test Results? - Healthline
    Mar 9, 2018 · CBC results are usually available to your doctor within 24 hours. Basic metabolic panel. This test measures common electrolytes in the blood as ...Procedure · Timing for blood test results · Blood testing and location
  30. [30]
    Clinical Laboratory Improvement Amendments (CLIA) - CMS
    Aug 29, 2025 · The objective of CLIA is to ensure quality laboratory testing. In 1988, Congress passed CLIA regulations to establish quality standards for all testing ...
  31. [31]
    CLIA Requirements for Analytical Quality 1992 - Westgard QC
    The tables below contain information on CLIA proficiency testing criteria for acceptable analytical performance, as printed in the Federal Register.
  32. [32]
    Basic metabolic panel - UCSF Health
    Jun 20, 2023 · The basic metabolic panel is a group of blood tests that provides information about your body's metabolism.
  33. [33]
    Creatinine test - Mayo Clinic
    Jun 12, 2025 · Your healthcare professional may ask you not to eat overnight before the test. This is called fasting. For a creatinine urine test, you may need ...Missing: basic metabolic
  34. [34]
    Normal reference ranges for laboratory values in pregnancy
    May 16, 2025 · INTRODUCTION. Numerous physiologic changes occur during pregnancy to accommodate maternal and fetal needs. Most of these changes begin soon ...
  35. [35]
    Evaluation and comparison of Abbott Jaffe and enzymatic creatinine ...
    Feb 24, 2017 · However, enzymatic method was found to have better performance in low creatine levels. Jaffe method was found 7% higher in the lower limit of ...
  36. [36]
    Effect of serum creatinine difference between the Jaffe and the ...
    Aug 3, 2023 · On average, SCr determined with the Jaffe method was 0.07 mg/dl higher than SCr determined with the enzymatic method. Ninety-five percent of the ...INTRODUCTION · MATERIALS AND METHODS · RESULTS · DISCUSSION
  37. [37]
    Reference Ranges and What They Mean - Testing.com
    Jul 9, 2021 · For example, the range used to evaluate a creatinine test result depends on a person's age and sex as shown in the table below.About Reference Ranges · Where Are The Reference... · How Are Reference Ranges...
  38. [38]
    Hyponatremia in Heart Failure - PMC - NIH
    Hyponatremia is the most common electrolyte disorder and is frequently encountered in patients with advanced heart failure.
  39. [39]
    Acute Kidney Injury - StatPearls - NCBI Bookshelf - NIH
    Nov 25, 2023 · Increase in serum creatinine by 0.3 mg/dL or more (26.5 μmol/L or more) within 48 hours. Increase in serum creatinine to 1.5 times or more than ...Continuing Education Activity · Introduction · Etiology · Evaluation
  40. [40]
    Acute Kidney Injury: A Guide to Diagnosis and Management - AAFP
    Oct 1, 2012 · Acute kidney injury is characterized by abrupt deterioration in kidney function, manifested by an increase in serum creatinine level with or without reduced ...
  41. [41]
    Anion Gap Blood Test: What It Is, Purpose, Risks & Results
    The anion gap reveals whether your blood has an imbalance of electrolytes or if your blood is too acidic or too basic. If you have too much acid in your blood, ...Metabolic Alkalosis · Metabolic Acidosis · Hypoalbuminemia
  42. [42]
    Pseudohyponatremia - StatPearls - NCBI Bookshelf - NIH
    Pseudohyponatremia, unlike true hyponatremia associated with low serum osmolality, is an artifact resulting from blood sample processing for sodium measurement.Missing: BMP | Show results with:BMP
  43. [43]
    Pseudohyponatremia - Acutecaretesting.org
    PSEUDOHYPONATREMIA AND DISSOLVED SOLIDS​​ Most commonly, it is caused by severe hypertriglyceridemia (serum triglyceride usually >1500 mg/dL or >17 mmol/L) and, ...Missing: BMP | Show results with:BMP
  44. [44]
    BMP Blood Test (Basic Metabolic Panel) - Testing.com
    Sep 2, 2022 · The basic metabolic panel (BMP) includes eight separate measurements taken from one blood sample and is used to evaluate kidney function and ...
  45. [45]
    Prediabetes and Type 2 Diabetes: Screening - uspstf
    Aug 24, 2021 · Recommendation Summary​​ The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or ...
  46. [46]
    The Adult Well-Male Examination - AAFP
    Dec 15, 2018 · The USPSTF recommends annual screening for lung cancer with low-dose computed tomography in adults 55 to 80 years of age who have at least a 30 ...Missing: metabolic | Show results with:metabolic
  47. [47]
    The Basic Metabolic Profile in Heart Failure-Marker and Modifier
    Elevated creatinine, increased blood urea nitrogen, hyponatremia, and hypochloremia correlate with worse mortality and diuretic resistance in heart failure.
  48. [48]
    Monitoring renal function during chemotherapy - PubMed
    Renal function is monitored during chemotherapy because chemotherapeutic drugs are excreted by the kidneys and are potentially nephrotoxic.
  49. [49]
    Diuretic Therapy for Patients With Heart Failure: JACC State-of-the ...
    Mar 17, 2020 · Loop diuretics are one of the cornerstones of treatments for heart failure, but there is sparse robust clinical trial evidence to guide use.
  50. [50]
    Hyperkalemia - StatPearls - NCBI Bookshelf
    Hyperkalemia is defined as a serum or plasma potassium level above the upper limits of normal, usually greater than 5.0 mEq/L to 5.5 mEq/L.Hyperkalemia · Pathophysiology · Treatment / ManagementMissing: panel | Show results with:panel
  51. [51]
    Hyperkalemia management in the emergency department - NIH
    Oct 1, 2021 · This article summarizes information on available therapies for hyperkalemia and proposes a hyperkalemia treatment algorithm for the ED practitioner.Missing: trauma | Show results with:trauma
  52. [52]
    Sepsis: Diagnosis and Management - AAFP
    Apr 1, 2020 · Laboratory testing should include a complete blood count with differential; basic metabolic panel; lactate, procalcitonin, and liver enzyme ...Missing: CO2 | Show results with:CO2
  53. [53]
    Hyponatremia - Knowledge @ AMBOSS
    Oct 28, 2025 · Hyponatremia is typically caused by fluid imbalance; common causes ... blood can cause falsely low serum sodium levels (pseudohyponatremia).
  54. [54]
    The BMP Decoded - Straight A Nursing
    Aug 8, 2023 · Signs and symptoms of hyponatremia can range from confusion and lethargy to seizures and coma. In general, the sodium level will be of great ...Missing: differentiate | Show results with:differentiate
  55. [55]
    Diabetic Ketoacidosis - Endotext - NCBI Bookshelf - NIH
    Apr 28, 2018 · DIAGNOSTIC TESTS NEEDED · Initial Necessary Tests. Basic metabolic panel, osmolality, ketones, β-hydroxybutyrate (β-OH), complete blood count ...Missing: sepsis | Show results with:sepsis
  56. [56]
    Diabetic Ketoacidosis (DKA) Workup - Medscape Reference
    Mar 21, 2024 · Initial workup should include aggressive volume, glucose, and electrolyte management. It is important to be aware that high serum glucose levels ...
  57. [57]
    Pre-Analytical, Analytical and Post-Analytical Factors Influencing ...
    This presentation aims to provide an overview of pre-analytical, analytical and post-analytical factors influencing specific tests for diagnosis and monitoring ...Missing: panel | Show results with:panel
  58. [58]
    Hemolysis and Lipemia Interference With Laboratory Testing - NIH
    For instance, hemolysis may cause a patient with normal plasma potassium to have a specimen with potassium in the hyperkalemia range. Clinical actions to lower ...
  59. [59]
    Identification of Clinical Biomarkers for Pre-Analytical Quality Control ...
    Based on these findings, a simple formula (glucose decrease by 1.387 mg/dL per hour) was derived to estimate the length of time delay after blood collection. ...
  60. [60]
    Evaluation of the impact of delayed centrifugation on the diagnostic ...
    This study aimed to determine if a time delay in the centrifugation of serum samples affected the creatinine level and the estimated glomerular filtration rate.Missing: BUN panel
  61. [61]
    Preparation for blood tests: what can go wrong before the sample ...
    Aug 12, 2025 · Various patient factors can affect laboratory test results, including posture, fasting status, circadian variation, medications and other ...Patient Preparation · Sample Collection · Avoiding HaemolysisMissing: basic metabolic panel
  62. [62]
    The effects of physical exercise on the assessment of kidney function
    May 15, 2020 · Physical exercise may lead to an acute rise in creatinine serum concentrations (SCr) due to increased creatinine release from muscle cells ...
  63. [63]
    Circadian control of glucose metabolism - PMC - PubMed Central
    The daily rise in plasma glucose concentrations at awakening could either result from a decrease in glucose uptake or from an increase in glucose output.
  64. [64]
    Errors within the total laboratory testing process, from test selection ...
    There is now incontrovertible evidence that the vast majority of laboratory errors occur in the preanalytical phase (61.9 - 68.2%), which are then followed by ...Missing: basic metabolic
  65. [65]
    Measurement of Serum Creatinine – Current Status and Future Goals
    Overestimation of creatinine ... Development of an automatic kinetic Jaffe method designed to minimise bilirubin interference in plasma creatinine assays.
  66. [66]
    Interferences from blood collection tube components on clinical ...
    Feb 15, 2014 · Abstract. Improper design or use of blood collection devices can adversely affect the accuracy of laboratory test results.
  67. [67]
    Electronic Health Records (EHR) Market Trends and Global
    Sep 30, 2025 · The global electronic health records market is estimated to grow from USD 36 billion in 2025, to USD 93 billion by 2035, at a CAGR of 8.89% ...
  68. [68]
    BMP vs CMP: Comparing Metabolic Panels
    ### Components of BMP and CMP
  69. [69]
    CMP vs. BMP: What's the Difference Between the Two Blood Panels?
    May 4, 2018 · A basic metabolic panel (BMP) measures the essential metabolic components of your blood. A comprehensive metabolic panel (CMP) measures substances produced by ...Collection · Uses · Normal ranges<|control11|><|separator|>
  70. [70]
    Metabolic Panel | Effective Health Care (EHC) Program
    A metabolic panel is a group of tests that measures different chemicals in the blood. These tests are usually done on the fluid (plasma) part of blood.<|control11|><|separator|>
  71. [71]
  72. [72]
    How Much Does a BMP (Basic Metabolic Panel) Cost Near Me?
    The cost of a BMP (Basic Metabolic Panel) ranges from $11 to $79. Those on high deductible health plans or without insurance can shop, compare prices and save.